Below are the most recent publications written about "Weight Loss" by people in Profiles.
-
Lalama E, Zhang J, Schuppelius B, Csanalosi M, Ruether KJA, Kabisch S, Mai K, Kraenkel N, Latz E, Christ A, Trico D, Mari A, Pfeiffer AFH. Glucagon and beta-cell function changes before and after dietary weight loss-induced metabolic improvements in type 2 diabetes. Diabetes Res Clin Pract. 2026 Aug; 238:113382.
-
Zhao B, Sullivan TB, Gupta P, Hooper K, Nudel J, Rieger-Christ K, Nepomnayshy D. Identifying microRNA predictors of weight loss after bariatric surgery. Surg Obes Relat Dis. 2026 Jul; 22(7):775-780.
-
Kwasnicka D, Palacz-Poborczyk I, Verboon P, Luszczynska A, Quested E, Robinson S, Gao L, Januszewicz A, Hagger MS, Pagoto S, Idziak P, Naughton F. A randomized controlled trial testing a digital intervention to promote weight loss and weight loss maintenance. Health Psychol. 2026 Sep; 45(9):893-906.
-
Schuppelius B, Lalama E, Zhang J, Ruether K, Csanalosi M, Kabisch S, Christ A, Latz E, Kraenkel N, Pivovarova-Ramich O, Mai K, Pfeiffer AFH. Remission of type 2 diabetes depends on time since diagnosis and low-calorie diet composition: Results of a randomized controlled trial in individuals with overweight and obesity. Diabetes Res Clin Pract. 2026 Mar; 233:113159.
-
Rodrigues A, Sweigert E, Robinson D, Kregel M, Williamson J, Koehler A, Schreckengast S, Forry C, Loeven K, Puffenberger E, McVey A, Hendrickson C, Patel A, Thomas A, Thomas S, Brigatti KW, Strauss K, Meier GL. Metformin therapy to facilitate weight loss in adults with classic maple syrup urine disease. Mol Genet Metab. 2026 Mar; 147(3):109730.
-
Koeller E, Romanelli J. The Role of Bariatric Surgery in the Era of GLP-1 Receptor Agonists. R I Med J (2013). 2025 Dec 01; 108(12):24-28.
-
Pagoto S, Xu R, Bannor R, Idiong C, Goetz J, Fernandes D. Comparing Synchronous and Asynchronous Remotely Delivered Lifestyle Interventions: Protocol for a Randomized Noninferiority Trial. JMIR Res Protoc. 2024 12 19; 13:e65323.
-
Valdecantos MP, Ruiz L, Folgueira C, Rada P, Gomez-Santos B, Solas M, Hitos AB, Field J, Francisco V, Escalona-Garrido C, Zagmutt S, Calderon-Dominguez M, Mera P, Garcia-Martinez I, Maym?-Masip E, Grajales D, Alen R, Mora A, S?inz N, Vides-Urrestarazu I, Vilarrasa N, Arbones-Mainar JM, Zaragoza C, Moreno-Aliaga MJ, Aspichueta P, Fern?ndez-Veledo S, Vendrell J, Serra D, Herrero L, Schreiber R, Zechner R, Sabio G, Hornigold D, Rondinone CM, Jermutus L, Grimsby J, Valverde ?M. The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk. Nat Commun. 2024 11 28; 15(1):10342.
-
Brown H, Brandt DR, Chen J, Hawkins K, Dong KR, Altman W. Effect of a Family Medicine Wellness Group Program on Long-Term Weight Loss Maintenance Outcomes. J Am Board Fam Med. 2024 Nov-Dec; 37(6):1038-1046.
-
Pagoto SL, Goetz JM, Xu R, Wang ML, Palmer L, Lemon SC. Randomized non-inferiority trial comparing an asynchronous remotely-delivered versus clinic-delivered lifestyle intervention. Int J Obes (Lond). 2025 01; 49(1):76-83.